Advanced Sterilization Products

Advanced Sterilization Products

Pre-clinical
Irvine, United StatesFounded 1987asp.com

Advanced Sterilization Products (ASP) is a critical player in the global infection prevention market, developing and commercializing advanced sterilization and disinfection technologies for medical devices. The company's flagship STERRAD™ systems represent a leading low-temperature sterilization platform, while their recent BIOTRACE™ innovation delivers biological indicator results in just 7 seconds, dramatically improving workflow efficiency in sterile processing departments. ASP focuses on addressing emerging challenges in device reprocessing, including compatibility with complex instruments like duodenoscopes, while promoting staff safety through emissions control and compliance with evolving regulatory standards.

Founded
1987
Focus
Medical Devices

AI Company Overview

Advanced Sterilization Products (ASP) is a critical player in the global infection prevention market, developing and commercializing advanced sterilization and disinfection technologies for medical devices. The company's flagship STERRAD™ systems represent a leading low-temperature sterilization platform, while their recent BIOTRACE™ innovation delivers biological indicator results in just 7 seconds, dramatically improving workflow efficiency in sterile processing departments. ASP focuses on addressing emerging challenges in device reprocessing, including compatibility with complex instruments like duodenoscopes, while promoting staff safety through emissions control and compliance with evolving regulatory standards.

Technology Platform

ASP's core technology platform is low-temperature hydrogen peroxide plasma sterilization (STERRAD™ systems) for medical devices, complemented by a novel fluorescent detection platform (BIOTRACE™) that provides biological indicator results in 7 seconds.

Opportunities

ASP's key growth opportunities include expanding adoption of its revolutionary 7-second BIOTRACE™ monitoring system to improve hospital workflow efficiency, addressing the critical need for safe and effective reprocessing of complex devices like duodenoscopes, and providing solutions for emerging environmental and safety standards regarding chemical emissions in sterile processing departments.

Risk Factors

Major risks include dependence on parent company strategic priorities, intense regulatory scrutiny on device reprocessing (especially for endoscopes), competitive innovation from rivals like Steris and Getinge, and ongoing pricing pressures from healthcare cost containment initiatives.

Competitive Landscape

ASP's main competitors are large medical technology conglomerates like Steris plc and Getinge AB, which offer broad portfolios of sterilization equipment. ASP differentiates through its specialized leadership in low-temperature hydrogen peroxide plasma technology (STERRAD™) and its groundbreaking speed advantage in biological monitoring with the BIOTRACE™ instant-read system.

Company Info

TypeServices
Founded1987
LocationIrvine, United States
StagePre-clinical
RevenueRevenue Generating

Contact

Therapeutic Areas

Infection PreventionSterile Processing
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile